SELE and psoriasis: Patients with psoriasis who were treated with etanercept showed decreased blood levels of cardiovascular biomarkers, such as soluble VCAM-1, soluble ICAM-1, soluble E-selectin, MMP-9, MPO, and tPAI-1 [249].